Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Bio-Techne (TECH) over the last 12 years, with Q4 2025 value amounting to $2.2 million.

  • Bio-Techne's Interest Expenses rose 107.08% to $2.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $9.3 million, marking a year-over-year decrease of 1428.31%. This contributed to the annual value of $8.5 million for FY2025, which is 4592.65% down from last year.
  • Bio-Techne's Interest Expenses amounted to $2.2 million in Q4 2025, which was up 107.08% from $2.9 million recorded in Q3 2025.
  • Over the past 5 years, Bio-Techne's Interest Expenses peaked at $4.9 million during Q3 2023, and registered a low of $1.4 million during Q1 2023.
  • Moreover, its 5-year median value for Interest Expenses was $2.6 million (2021), whereas its average is $2.9 million.
  • Over the last 5 years, Bio-Techne's Interest Expenses had its largest YoY gain of 19297.73% in 2024, and its largest YoY loss of 5552.83% in 2024.
  • Bio-Techne's Interest Expenses (Quarter) stood at $2.9 million in 2021, then dropped by 18.81% to $2.4 million in 2022, then soared by 83.74% to $4.3 million in 2023, then tumbled by 50.38% to $2.1 million in 2024, then increased by 1.07% to $2.2 million in 2025.
  • Its Interest Expenses stands at $2.2 million for Q4 2025, versus $2.9 million for Q3 2025 and $2.2 million for Q2 2025.